Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOL™ to affected skin and subsequent exposure of that skin to energy of a wavelength capable of activating the photosensitizer.
1 . A method to treat hyperactive sebaceous gland disorders which method comprises:
(i) topically applying a hydrophobic and/or lipophilic photosensitizer composition to skin tissue exhibiting symptoms of acne, and
(ii) exposing the tissue to energy at a wavelength capable of activating the photo sensitizer.
2 . The method of claim 1 wherein the disorder is selected from acne, seborrhea, seborrheic dermatitis, and sebaceous gland hyperplasia.
3 . The method of claim 1 , wherein the photosensitizer is selected from lipophilic photosensitizers.
4 . The method of claim 1 , wherein the photosensitizer is selected from hydrophobic photosensitizers.
5 . The method of claim 1 , wherein the photosensitizer is selected from the group consisting of 5-aminolevulinic acid and derivatives thereof, 5-aminolevulinic acid esters and derivatives thereof, porphyrins and derivatives thereof, methylene blue and derivatives thereof, bacteriochlorophyll and derivatives thereof, and combinations thereof.
6 . The method of claim 1 , wherein the photosensitizer is selected from the group consisting of 5-aminolevulinic acid, 5-aminolevulinic acid esters, chlorins, bacteriochlorins, isobacteriochlorins, phthalocyanine, naphthalocyanines, pyropheophorbides, sapphyrins, texaphyrins, tetrahydrochlorins, purpurins, porphycenes, phenothiaziniums, bacteriochlorophyll, bacteriochlorophyll derivatives, pro-porphyrins, porphyrins, and combinations thereof.
7 . The method of claim 1 , wherein the photosensitizer is selected from the group consisting of verteporfin, lemuteporfin, and combinations thereof.
8 . The method of claim 1 , wherein the composition has a viscosity at 20° C. of from about 50 cps to about 50,000 cps.
9 . The method of claim 1 , wherein excess photosensitizer composition is removed from the skin prior to application of said energy.
10 . The method of claim 1 , wherein the hyperactive sebaceous gland disorder is acne and the treatment is repeated until the total number of acne lesions has been reduced by 30% or greater.
11 . The method of claim 1 , wherein steps i) and ii) are repeated at least once every six months.
12 . The method of claim 1 , wherein steps i) and ii) are repeated at least once every three months.
13 . The method of claim 1 , wherein steps (i) and (ii) are repeated at intervals of not less than 5 days.
14 . The method of claim 1 , wherein the hyperactive sebaceous gland disorder is acne and the treatment method further includes at least one non-photodynamic treatment for acne.
15 . The method of claim 14 , wherein the non-photodynamic treatment at least one topical treatment.
16 . The method of claim 14 , wherein the non-photodynamic treatment is administering one or more agents selected from the group consisting of topical retinoids, oral retinoids, systemic antibiotics, topical or local antibiotics, oral contraceptives, topical anti-androgens, anti-progestins, blue light therapy, laser therapy, and combinations thereof.
17 . The method of claim 14 wherein the non-photodynamic treatment comprises administering one or more topical retinoids.
18 . The method of claim 1 , wherein said energy is at least in part supplied by a light emitting diode device.
19 . The method of claim 18 wherein the device emits red and blue light.
20 - 21 . (canceled)